phosphoserine has been researched along with celecoxib in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arico, S; Barbat, A; Bauvy, C; Codogno, P; Gane, P; Ogier-Denis, E; Pattingre, S | 1 |
| Chao, JI; Hsiao, PW; Liu, HF | 1 |
2 other study(ies) available for phosphoserine and celecoxib
| Article | Year |
|---|---|
Celecoxib induces apoptosis by inhibiting 3-phosphoinositide-dependent protein kinase-1 activity in the human colon cancer HT-29 cell line.
Topics: 3-Phosphoinositide-Dependent Protein Kinases; Apoptosis; Celecoxib; Cell Survival; Colonic Neoplasms; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Humans; Kinetics; Phosphorylation; Phosphoserine; Phosphothreonine; Protein Kinases; Protein Serine-Threonine Kinases; Pyrazoles; Sulfonamides; Tumor Cells, Cultured | 2002 |
Celecoxib induces p53-PUMA pathway for apoptosis in human colorectal cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Celecoxib; Cell Death; Cell Line, Tumor; Cell Survival; Colorectal Neoplasms; Drug Screening Assays, Antitumor; Humans; Membrane Potential, Mitochondrial; Mitochondria; Mutation; Neoplasm Proteins; Phosphorylation; Phosphoserine; Protein Transport; Proto-Oncogene Proteins; Pyrazoles; Securin; Sulfonamides; Tumor Suppressor Protein p53 | 2008 |